MedTrace Logo

Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse

NCT03577301 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2024-09-03

Study results available
· View outcomes & findings →

Summary

YMHP is a counseling intervention program for which the goals are to better understand HIV-prevention focused self-management behaviors among HIV-negative YMSM, and to study the implementation of YMHP to improve portability and scalability. The clinic sites will help investigators to assess and address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce HIV infection among YMSM that reflects the complexities of real world adolescent HIV clinics.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Clinic-based Delivery

A minimum of 2 community health workers (CHWs) will be trained to deliver clinic-based intervention sessions.

BEHAVIORAL

Remote Delivery

A minimum of 2 community health workers (CHWs) will be trained to deliver intervention sessions to the participant in a location remote from the clinic setting.

BEHAVIORAL

Multi-modal Delivery

A minimum of 2 community health workers (CHWs) will be trained to deliver clinic-based or remote intervention sessions. First MI session is in person immediately after baseline. Sessions 2-4 can be delivered in person or remotely based on youth preference.

Sponsors & Collaborators

  • Florida State University

    lead OTHER

Principal Investigators

  • Sylvie Naar, PhD · Florida State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-04
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577301 on ClinicalTrials.gov